Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans.
about
Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study.The effect of L-arginine and creatine on vascular function and homocysteine metabolism.The role of dietary creatine.Low-Dose Creatine Supplementation Lowers Plasma Guanidinoacetate, but Not Plasma Homocysteine, in a Double-Blind, Randomized, Placebo-Controlled TrialCreatine metabolism and safety profiles after six-week oral guanidinoacetic acid administration in healthy humans.Whole body creatine and protein kinetics in healthy men and women: effects of creatine and amino acid supplementation.Maternal dietary creatine supplementation does not alter the capacity for creatine synthesis in the newborn spiny mouseCreatine synthesis: hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo.Normal and pathologic concentrations of uremic toxins.Guanidinoacetic acid as a performance-enhancing agent.Short-term creatine supplementation does not reduce increased homocysteine concentration induced by acute exercise in humans.Creatine synthesis: production of guanidinoacetate by the rat and human kidney in vivo.Creatine supplementation to total parenteral nutrition improves creatine status and supports greater liver and kidney protein synthesis in neonatal piglets.Effects of l-arginine and creatine administration on spatial memory in rats subjected to a chronic variable stress model.Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine.The role of L-arginine/L-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients.
P2860
Q33412387-6E125201-E636-4DBA-A6CA-2F5AA7169486Q33734265-A05BDCE0-7AEA-4CB1-922E-07E341355644Q34514017-2654F8C5-73A8-473A-B360-75356FBC7101Q36087847-A095D596-0B21-44D6-B631-3739E05A35DAQ36540109-4693C553-8EBA-4560-8705-47B0DB3A2158Q36581749-35C274CB-F4AC-4A25-88D1-B118937DC86CQ37100555-40299836-A599-4AFD-A952-DA801C909C73Q37102847-D04B6042-E3ED-4020-90B9-A8626F2D7B1AQ38012908-0FBE9F23-6445-4848-A9F9-25280D35BE4AQ38601629-67D227B3-F6A5-4A71-8D7D-9E03363FE22DQ43643683-69E1D743-53A9-4A5F-9821-AD688762B0F9Q46956803-5921FBC9-CF43-4A9A-8A75-065057CB5437Q47896823-87F35A7C-7F28-4C6A-A13A-3D7ECB7ED7DFQ50680134-9EB3EFD3-A0E3-4B36-9189-21A64A61ECCCQ50783438-AE032BAE-A6FD-4648-8FC4-0AD65C71A9EAQ51101402-4939B80E-5074-4CBD-B406-523C8709A3FD
P2860
Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Plasma guanidino compounds are ...... lementation in healthy humans.
@en
Plasma guanidino compounds are ...... lementation in healthy humans.
@nl
type
label
Plasma guanidino compounds are ...... lementation in healthy humans.
@en
Plasma guanidino compounds are ...... lementation in healthy humans.
@nl
prefLabel
Plasma guanidino compounds are ...... lementation in healthy humans.
@en
Plasma guanidino compounds are ...... lementation in healthy humans.
@nl
P2093
P2860
P1476
Plasma guanidino compounds are ...... lementation in healthy humans.
@en
P2093
Bart Marescau
Bert O Eijnde
Els Vanden Eede
Peter Hespel
Peter P De Deyn
P2860
P304
P356
10.1152/JAPPLPHYSIOL.00206.2004
P407
P50
P577
2004-04-23T00:00:00Z